论文部分内容阅读
肺癌的发病率逐年上升,而肺癌的早期诊断、早期手术尚有困难,联合化疗在晚期非小细胞肺癌(NSCLC)的综合治疗中占有重要地位.近年来国内外学者先后报道了多种用于NSCLC治疗的化疗方案.为找到一个更有效的化疗方案,我科采用法国Pierre Faber药厂生产的诺维本联合顺铂及丝裂霉素即
The incidence of lung cancer increases year by year, and early diagnosis and early surgery of lung cancer are still difficult. Combined chemotherapy plays an important role in the comprehensive treatment of advanced non-small cell lung cancer (NSCLC). In recent years, scholars at home and abroad have reported a variety of applications. Chemotherapy for NSCLC treatment. In order to find a more effective chemotherapy regimen, our company uses Novell’s Pierre Faber Pharmaceutical Company to manufacture novbosin in combination with cisplatin and mitomycin.